Health, life sciences, and research-driven stories.
Telix to Acquire Isotope Maker ITM in $2.35 Billion Deal
Novartis Ends ALS Drug Development After Mid-Stage Trial Fails
Apollo to Shutter Some Invoice-Financing Products at Eliant